Market Overview

UPDATE: Stifel Nicolaus Raises PT to $117 on Stericycle Following Solid Q4

Share:
Related SRCL
Imperial Capital Initiates Stericycle With In-line
Benzinga's Top Initiations
Stericycle's (SRCL) CEO Charles Alutto on Q1 2015 Results - Earnings Call Transcript (Seeking Alpha)

Stifel Nicolaus reiterated its Buy rating on Stericycle (NASDAQ: SRCL) and raised the price target from $102.00 to $117.00.

Stifel Nicolaus commented, "SRCL posted another solid quarter and raised guidance again. Revenue and EPS were ahead of estimates, though FCF came in within the expected range. We believe SRCL has largely completed the platform acquisitions it was making in the Patient Communications space that were weighing on company margins (they were declining), and margins have improved in each of the last two quarters."

Stericycle closed at $95.12 on Wednesday.

Latest Ratings for SRCL

DateFirmActionFromTo
Mar 2015Imperial CapitalInitiates Coverage onIn-line
Nov 2014Bank of AmericaMaintainsBuy
Sep 2014Goldman SachsDowngradesBuyNeutral

View More Analyst Ratings for SRCL
View the Latest Analyst Ratings

Posted-In: Stifel NicolausAnalyst Color Price Target Analyst Ratings

 

Related Articles (SRCL)

Around the Web, We're Loving...